Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atomized Intraperitoneal Saline (AIS) is a sterile 0.9% sodium chloride solution administered as an atomized spray into the peritoneal cavity at the completion of surgery. Developed for use in clinical research by Loyola University, specifically in the Phase 4 SPRAY trial, AIS serves as a placebo control to evaluate the efficacy of atomized local anesthetics like ropivacaine for postoperative pain management in patients undergoing robotic-assisted pelvic surgery. The atomization technique is intended to provide uniform distribution of the saline across the peritoneal surfaces, allowing researchers to control for the physical effects of the delivery method and fluid volume when assessing the analgesic properties of the active drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Atomized Intraperitoneal Saline.